MEDGF OTC
Medacta Group S.A.
1W: +0.0%
1M: -14.1%
3M: +63.9%
YTD: +63.9%
1Y: +63.9%
3Y: +66.6%
5Y: +14.1%
$137.50
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$154M
+43.4% ▲
5Y CAGR: +20.8%
Capital Expenditures
$124M
-18.2% ▼
5Y CAGR: +35.3%
Free Cash Flow
$30M
+1119.0% ▲
5Y CAGR: -1.5%
Dividends Paid
$15M
-31.8% ▼
Buybacks
$6M
-29.9% ▼
Net Change in Cash
$5M
-50.0% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $52M | $46M | $47M | $73M | $96M |
| Depreciation & Amort. | $35M | $43M | $58M | $65M | $75M |
| Stock-Based Comp. | $468K | $1M | $2M | $4M | $0 |
| Change in Working Capital | -$31M | -$39M | -$41M | -$37M | -$27M |
| Other Non-Cash Items | -$33M | -$16M | $8M | $2M | $321K |
| Operating Cash Flow | $54M | $74M | $75M | $107M | $154M |
| — Investing Activities — | |||||
| Capital Expenditures | -$46M | -$63M | -$71M | -$89M | -$144M |
| Acquisitions (Net) | $0 | -$220K | $0 | $0 | $5M |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $1M |
| Other Investing | -$6M | -$2M | -$9M | -$10M | $0 |
| Investing Cash Flow | -$52M | -$65M | -$81M | -$99M | -$138M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$30M | $17M | $14M | $31M | $14M |
| Stock Repurchased | -$1M | -$3M | -$4M | -$5M | -$6M |
| Dividends Paid | $0 | -$10M | -$11M | -$11M | -$15M |
| Other Financing | $0 | $0 | -$9M | -$10M | -$12M |
| Financing Cash Flow | -$31M | $3M | -$10M | $4M | -$19M |
| Net Change in Cash | -$28M | $12M | -$11M | $11M | $5M |
| Cash End of Period | $20M | $32M | $21M | $32M | $33M |
| Free Cash Flow | $8M | $10M | -$7M | $2M | $30M |